Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study
Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received partial 12-week (final) body weight results from the recently completed animal study WEIGHT-A24-1 (the "Study").Animal Weights (grams)DehydraTECHGroupsEnd ofAcclimationPeriodDay28% Changeto Day28Day56%Changeto Day56Day84%Changeto Day84A: CBD1427.9432.6+1.10%438.0+2.36%432.3+1.046%B:...
Read more








